Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes (Q32050057)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes
scientific article

    Statements

    Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes (English)
    E B Rappaport
    Rosiglitazone Clinical Trials Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit